中文
Tahoe Investment officially acquires a US listed company - Alliance and sets foot in its international march
Share to:
 Wed, 30 Mar 2016 10:20:43 GMT | views:4214

In the early morning on March 29, 2016 according to local time, American listed company NASDAQ - Alliance Healthcare Services, (NASDAQ: AIQ, hereinafter referred to as “Alliance”) announced that Tahoe Investment Group Co. Ltd. (hereinafter referred to as “Tahoe Investment”) has completed the acquisition of 51.5% of equities of that company and thus become its controlling shareholder. Mr. Huang Qisen, the founder and chairman of Tahoe Investment Co., Ltd. has been appointed as chairman of the board of that company since the above date.

This marks the success of acquisition of American medical listed company by Tahoe Investment Group which has received widespread concern since last year. Thereby, Tahoe Investment Group has set foot in its international march towards oversea markets.


The website homepage of American Alliance Healthcare Services, Inc.

http://www.alliancehealthcareservices-us.com/


Established in 1996, Tahoe Investment Group is a listed company in China - Tahoe Group Co., Ltd. (SZ.000732, hereinafter referred to as “Tahoe Group”), of which the largest shareholder and controlling shareholder is Huang Qisen, the founder and chairman of Tahoe Group. The total asset of Tahoe Investment Group exceeds USD 13 billion, covering such fields as real estate development, finance, security and biomedicine. Previously, Tahoe Investment Group acquired Fujian Huitian Bio-Pharmaceutical Company and this acquisition of American Alliance will help it expand its business development in medical field in both China mainland and oversea markets.

Alliance is the leading supplier of American out-sourcing medical and health services, serving hospitals and medical institutions throughout the US. The company mainly operates radiation outpatient, oncotherapy and intervention services clinics independent from hospitals and medical institutions, as well as Ambulatory Surgery Centers (ASC). The company provides patients with medical services such as radiation diagnosis, oncotherapy and intervention and pain management through its subordinate imaging department, tumor radiotherapy department and intervention therapy department. The company is the largest American supplier of mobile image diagnostic service, leading industry service provider of hospital stagnation image and leading American supplier of stereotactic radiosurgery. Up to December 31, 2015, the company serves and manages 563 imaging diagnosis and oncotherapy equipment, among which 116 are distributed in hospital stagnation radiation centers throughout various states of the US; meanwhile, it is in charge of the operation of relevant therapy facilities through 32 radiation therapy centers. The company has established long-term strategic partnership with more than 1,000 hospitals, medical institutions, health management departments and physicians’ associations throughout 45 states of the US and provides excellent nursing service for patients through 2,430 professional medical staff working in the company.

Report screenshots from American Yahoo website

It is reported that after Tahoe Investment Group became the controlling shareholder of Alliance, in addition to helping consolidating its position in the US healthcare market, it will also help the company to march towards the Chinese medical field and bring excellent radiation and tumor treatment services to China, which provides Chinese patients with international leading medical service and improves the medical level of China. At present, the two parties are further negotiating and promoting the cooperation with notable hospitals in relevant Chinese cities.

On the same day, American Yahoo and local authoritative media of American business information website published formal English reports and below are the original ones: 


Fujian Thai Hot Investment Completes Purchase of a Majority Interest in Alliance HealthCare Services

    Alliance HealthCare Services, Inc. (AIQ) (the “Company”, “Alliance”, “we” or “our”), a leading national provider of outsourced radiology, oncology and interventional services, announced today that the Company entered into a Governance, Voting and Standstill Agreement (the “Governance Agreement”) with Fujian Thai Hot Investment Co., Ltd (“Fujian Thai Hot”) with respect to the acquisition by Fujian Thai Hot of 5,537,945 shares of common stock of the Company from funds managed by Oaktree Capital Management, L.P. and MTS Health Investors, LLC, and Larry C. Buckelew (together, the “Selling Stockholders”) (the “Transaction”). Fujian Thai Hot now owns an aggregate of approximately 51.5% of the outstanding common stock of the Company. The Company did not sell any shares in the Transaction.
    Tom Tomlinson, Chief Executive Officer and President of Alliance, commented, “We are thrilled to welcome our new partner, Fujian Thai Hot, and look forward to collaborating with our new Board Chairman Qisen Huang as well as Mr. Feng and Dr. Zhang as new Board members. Supported by leadership from Fujian Thai Hot, our team remains focused on executing against our long-term strategic growth plan, improving the long-term profitability of our business and enhancing the value proposition we provide to our customers. Additionally, Fujian Thai Hot’s international experience will help Alliance evaluate global opportunities as we look to expand our footprint, including capitalizing on opportunities in China and other global markets that have an unmet need for quality healthcare services.”
    Qisen Huang, Founder and Chairman of Fujian Thai Hot, and as of today, Chairman of the Alliance HealthCare Services Board of Directors (the “Board”), said, “The synergies between our two companies will support strategic growth of Alliance in the decades to come, while at the same time, provide Chinese patients with access to the American standard of healthcare. As we work toward achieving this goal together, we all are contributing to a greater good.”
    The Chairman continued, “I respect the great accomplishments that Alliance has made over the past decades which include being a market leader in medical imaging and radiation oncology, as well as accelerating growth in the fragmented pain management sector. I expect the Alliance leadership team to continue executing on its long-term strategies while sharing best practices with the Chinese market. Together, I trust that Fujian Thai Hot and Alliance can make a great difference and change the way healthcare is delivered in China, while continuing strong growth and innovation in the United States.”
Governance Agreement
    The Governance Agreement with Fujian Thai Hot is effective as of the closing of the Transaction. The Governance Agreement and other matters related to the Transaction were approved by a Special Committee of the Board composed of independent directors of the Company not affiliated with any Selling Stockholder.
    The Governance Agreement provides, in part, that Fujian Thai Hot and its affiliates are prohibited, for a period of three years from the date of the closing of the Transaction, from acquiring additional shares of the Company’s common stock without the prior consent of a majority of the unaffiliated directors, provided that, if Fujian Thai Hot’s beneficial ownership falls below 51.5% of the outstanding common stock, Fujian Thai Hot has the right to acquire additional shares to maintain its beneficial ownership at up to 51.5% if such right is exercised within 120 days of Fujian Thai Hot’s beneficial ownership level falling below such level.
Board Appointees
    Qisen Huang, Heping Feng and Tao Zhang were appointed to the Board. The new directors replaced Michael Harmon, Curtis Lane and Aaron Bendikson who resigned from the Board effective as of the closing of the Transaction. Mr. Feng and Mr. Zhang have each been appointed to serve on the Compensation and the Nominating and Corporate Governance Committees of the Board.
Credit Amendment
    In connection with the closing of the Transaction, the Company also entered into an Amendment to the Company’s Credit Agreement (the “Credit Amendment”). Under the Credit Amendment, the Company’s Credit Agreement was amended such that the sale of shares of Alliance by the Selling Stockholders to Fujian Thai Hot would not be deemed to constitute a change of control and the soft call provision was reinstated to commence on the date the Credit Amendment is effective and end the date that is twelve (12) months after such commencement.
About Alliance HealthCare Services
    Alliance HealthCare Services (AIQ) is a leading national provider of outsourced healthcare services to hospitals and providers. We also operate freestanding outpatient radiology, oncology and interventional services clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by hospitals or providers. Diagnostic radiology services are delivered through the Radiology Division (Alliance HealthCare Radiology), radiation oncology services are delivered through the Oncology Division (Alliance Oncology), and interventional and pain management services are delivered through the Interventional Services Division (Alliance HealthCare Interventional Partners). Alliance is the nation’s largest provider of advanced diagnostic mobile imaging services, an industry-leading operator of fixed-site imaging centers, and a leading provider of stereotactic radiosurgery nationwide. As of December 31, 2015, Alliance operated 563 diagnostic radiology and radiation therapy systems, including 116 fixed-site radiology centers across the country; and 32 radiation therapy centers and SRS facilities. With a strategy of partnering with hospitals, health systems and physician practices, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states, where approximately 2,430 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations. For more information, visit www.alliancehealthcareservices-us.com.
About Fujian Thai Hot Investment
    Fujian Thai Hot Investment Co., Ltd is an investment holding company based in Fuzhou, China, holding a diversified portfolio of assets in various industries including real estate development, securities, hospitality, biomedicine and healthcare. Fujian Thai Hot was founded in 1996 and its total assets exceeded $13 billion as of December 31, 2015. Fujian Thai Hot’s diversified portfolio includes controlling ownership in Thai Hot Group, one of the leading real-estate developers in China listed on the Shenzhen Stock Exchange (SZSE:000732). Fujian Thai Hot is also the third largest shareholder of the Shanghai Stock Exchange listed Dongxing Securities (601198.SS). Fujian Thai Hot expanded its business landscape to include biomedicine and healthcare industry by acquiring a large-scale pharmaceutical company. In early 2015, Fujian Thai Hot made healthcare and medical services one of its top priorities, including radiology and oncology, and it intends to expand healthcare services in mainland China to an underserved healthcare marketplace. Qisen Huang (also cited as “Kisum Wong”) is the Founder and Chairman of Fujian Thai Hot.
Forward-Looking Statements
    This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, without limitation, the Company’s long-term value proposition, growth and international market and other opportunities. Forward-looking statements can be identified by the use of forward looking language such as “believe,” “anticipate,” “expect,” “estimate,” “intend,” “plan,” “project,” “will be,” “will continue,” “will result,” “could,” “may,” “might,” or any variations of such words with similar meanings. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected. For a complete list of risks and uncertainties, please refer to the Risk Factors section of the Company’s Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission.

Text link: http://www.businesswire.com/news/home/20160329006492/en/


Copyright © 2016 Tahoe Investment Group. powered by HaiXi TianCheng